Tags: drugsRemove, pharmaceuticalsRemove

United Labs' renminbi-denominated convertible bond comes at attractive terms, but still falls below par.
By Anette Jönsson | 8 November 2011
IPO investors will need to weigh up United Laboratories' strong structural growth potential and generous valuation against a regulated market with plenty of competition and ...
By Anette Jönsson | 29 May 2007
Issue marks seventh CB from an Indian pharmaceutical company since December; conversion premiums still high.
By Anette Jönsson | 25 April 2006
1
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012